Skip to main content
Top
Gepubliceerd in: TSG - Tijdschrift voor gezondheidswetenschappen 6/2012

01-09-2012 | Service

Handleiding voor kostenonderzoek: methoden en referentieprijzen voor economische evaluaties in de gezondheidszorg

Auteurs: Siok Swan Tan, Clazien A. M. Bouwmans-Frijters, Leona Hakkaart-van Roijen

Gepubliceerd in: TSG - Tijdschrift voor gezondheidswetenschappen | Uitgave 6/2012

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

samenvatting

Het doel van de kostenhandleiding is het verschaffen van een instrument dat onderzoekers en beleidsmakers faciliteert bij de uitvoering en beoordeling van kostenonderzoek in economische evaluaties. In dit artikel wordt de kern van de kostenhandleiding 2010 beschreven en in een internationale context geplaatst aan de hand van het stappenplan voor kostenonderzoek. In dit stappenplan wordt het berekenen van kosten gezien als een proces waarbij zeven stappen chronologisch doorlopen worden. Waar duidelijke aanbevelingen worden gedaan voor de bepaling van de reikwijdte van de economische evaluatie (stap 1), de keuze van de kostencategorieën (stap 2), omgaan met onzekerheid (stap 6) en rapportage van kosten (stap 7), wordt de keuze met betrekking tot de identificatie (stap 3), volumemeting (stap 4) en waardering van eenheden (stap 5) neergelegd bij de onderzoeker. Hoewel de aanbevelingen in Nederland op specifieke onderwerpen iets afwijkt van andere Westerse landen, is het stappenplan voor kostenonderzoek vergelijkbaar met het proces dat beschreven wordt in de internationale richtlijnen. De kostenhandleiding sluit aan bij de uitgangspunten en de terminologie uit de Nederlandse richtlijnen voor farmaco-economisch onderzoek, maar de beschreven methoden kunnen ook in andere soorten onderzoekworden gebruikt.
Literatuur
1.
go back to reference Rutten-van Molken M. Van kosten tot effecten: een handleidingvoor evaluatiestudies in de gezondheidszorg. Maarssen; Elseviergezondheidszorg, 2010. Rutten-van Molken M. Van kosten tot effecten: een handleidingvoor evaluatiestudies in de gezondheidszorg. Maarssen; Elseviergezondheidszorg, 2010.
2.
go back to reference Commonwealth of Australia. Manual of recourse items and their associated costs 2009. Canberra: Commonwealth of Australia:, 2009. Commonwealth of Australia. Manual of recourse items and their associated costs 2009. Canberra: Commonwealth of Australia:, 2009.
3.
go back to reference Rodenburg-van Dieten HEM. Richtlijnen voor farmaco-economisch onderzoek; evaluatie en actualisatie. Diemen: College voor zorgverzekeringen, 2005. Rodenburg-van Dieten HEM. Richtlijnen voor farmaco-economisch onderzoek; evaluatie en actualisatie. Diemen: College voor zorgverzekeringen, 2005.
4.
go back to reference Tan SS, Bouwmans CAM, Rutten FFH, Hakkaart-van Roijen L. Update of the Dutch Manual for costing in economic evaluations. Int J Technol Assess Health Care; 28:2 (2012), 152–158.PubMedCrossRef Tan SS, Bouwmans CAM, Rutten FFH, Hakkaart-van Roijen L. Update of the Dutch Manual for costing in economic evaluations. Int J Technol Assess Health Care; 28:2 (2012), 152–158.PubMedCrossRef
5.
go back to reference Hjelmgren J, Berggren F, Andersson F. Health economic guidelines–similarities, differences and some implications. Value Health 2001;4:225–50.PubMedCrossRef Hjelmgren J, Berggren F, Andersson F. Health economic guidelines–similarities, differences and some implications. Value Health 2001;4:225–50.PubMedCrossRef
6.
go back to reference Rappange DR, Baal PH van, Exel NJ van et al. Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics 2008;26:815–30.PubMedCrossRef Rappange DR, Baal PH van, Exel NJ van et al. Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics 2008;26:815–30.PubMedCrossRef
7.
go back to reference Swindle R, Lukas CV, Meyer DA, Barnett PG, Hendricks AM. Cost analysis in the Department of Veterans Affairs: consensus and future directions. Med Care 1999;37:AS3–8.CrossRef Swindle R, Lukas CV, Meyer DA, Barnett PG, Hendricks AM. Cost analysis in the Department of Veterans Affairs: consensus and future directions. Med Care 1999;37:AS3–8.CrossRef
8.
go back to reference Clement Nee Shrive FM, Ghali WA, Donaldson C, Manns BJ. The impact of using different costing methods on the results of an economic evaluation of cardiac care: microcosting vs grosscosting approaches. Health Econ 2009;18:377–88.CrossRef Clement Nee Shrive FM, Ghali WA, Donaldson C, Manns BJ. The impact of using different costing methods on the results of an economic evaluation of cardiac care: microcosting vs grosscosting approaches. Health Econ 2009;18:377–88.CrossRef
9.
go back to reference Tan SS, Rutten FF, Ineveld BM van, Redekop WK, Hakkaart-van Roijen L. Comparing methodologies for the cost estimation of hospital services. Eur J Health Econ 2009;10: 39–45.PubMedCrossRef Tan SS, Rutten FF, Ineveld BM van, Redekop WK, Hakkaart-van Roijen L. Comparing methodologies for the cost estimation of hospital services. Eur J Health Econ 2009;10: 39–45.PubMedCrossRef
11.
go back to reference Ellwein LB, Drummond MF. Economic analysis alongside clinical trials. Bias in the assessment of economic outcomes. Int J Technol Assess Health Care 1996;12:691–7.PubMedCrossRef Ellwein LB, Drummond MF. Economic analysis alongside clinical trials. Bias in the assessment of economic outcomes. Int J Technol Assess Health Care 1996;12:691–7.PubMedCrossRef
12.
go back to reference Johnston K, Buxton MJ, Jones DR, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess 1999;3:1–76.PubMed Johnston K, Buxton MJ, Jones DR, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess 1999;3:1–76.PubMed
13.
go back to reference Raftery J, Roderick P, Stevens A. Potential use of routine databases in health technology assessment. Health Technol Assess 2005;9:1–92,iii–iv. Raftery J, Roderick P, Stevens A. Potential use of routine databases in health technology assessment. Health Technol Assess 2005;9:1–92,iii–iv.
14.
go back to reference Curtis L. Unit Costs of Health and Social Care 2010. Eighteenth edition. Canterbury: University of Kent, 2010. Curtis L. Unit Costs of Health and Social Care 2010. Eighteenth edition. Canterbury: University of Kent, 2010.
15.
go back to reference Krauth C, Hessel F, Hansmeier T, Wasem J, Seitz R, Schweikert B. Empirical standard costs for health economic evaluation in Germany – a proposal by the working group methods in health economic evaluation. Gesundheitswesen 2005;67:736–46.PubMedCrossRef Krauth C, Hessel F, Hansmeier T, Wasem J, Seitz R, Schweikert B. Empirical standard costs for health economic evaluation in Germany – a proposal by the working group methods in health economic evaluation. Gesundheitswesen 2005;67:736–46.PubMedCrossRef
16.
go back to reference Tan SS, Ineveld BM van, Redekop WK, Hakkaart-van Roijen L. The Netherlands: the Diagnose Behandeling Combinaties (DBCs). In: Busse R, Geissler A, Quentin W & Wiley MM (eds). Diagnosis-Related Groups in Europe: moving towards transparency, efficiency and quality in hospitals. Buckingham: Open University Press and WHO Regional Office for Europe, 2011. Tan SS, Ineveld BM van, Redekop WK, Hakkaart-van Roijen L. The Netherlands: the Diagnose Behandeling Combinaties (DBCs). In: Busse R, Geissler A, Quentin W & Wiley MM (eds). Diagnosis-Related Groups in Europe: moving towards transparency, efficiency and quality in hospitals. Buckingham: Open University Press and WHO Regional Office for Europe, 2011.
17.
go back to reference Goossens ME, Rutten-van Molken MP, Vlaeyen JW, Linden SM van der. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000; 53:688–95.PubMedCrossRef Goossens ME, Rutten-van Molken MP, Vlaeyen JW, Linden SM van der. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000; 53:688–95.PubMedCrossRef
18.
go back to reference Brink M van den, Hout WB van den, Stiggelbout AM et al. Selfreports of health-care utilization: diary or questionnaire? Int J Technol Assess Health Care 2005;21:298–304.PubMed Brink M van den, Hout WB van den, Stiggelbout AM et al. Selfreports of health-care utilization: diary or questionnaire? Int J Technol Assess Health Care 2005;21:298–304.PubMed
19.
go back to reference Wordsworth S, Ludbrook A, Caskey F, Macleod A. Collecting unit cost data in multicentre studies. Creating comparable methods. Eur J Health Econ 2005;6:38–44.PubMedCrossRef Wordsworth S, Ludbrook A, Caskey F, Macleod A. Collecting unit cost data in multicentre studies. Creating comparable methods. Eur J Health Econ 2005;6:38–44.PubMedCrossRef
20.
go back to reference Zuurbier J, Krabbe-Alkemade Y. Onderhandelen over DBC’s. Maarssen: Elsevier Gezondheidszorg, 2007. Zuurbier J, Krabbe-Alkemade Y. Onderhandelen over DBC’s. Maarssen: Elsevier Gezondheidszorg, 2007.
21.
go back to reference Jackson T. Cost estimates for hospital inpatient care in Australia: evaluation of alternative sources. Aust N Z J Public Health 2000;24:234–41.PubMedCrossRef Jackson T. Cost estimates for hospital inpatient care in Australia: evaluation of alternative sources. Aust N Z J Public Health 2000;24:234–41.PubMedCrossRef
22.
go back to reference Heerey A, McGowan B, Ryan M, Barry M. Microcosting versus DRGs in the provision of cost estimates for use in pharmacoeconomic evaluation. Expert Rev. PharmacoEconomics Outcomes Res 2002;2:29–33.CrossRef Heerey A, McGowan B, Ryan M, Barry M. Microcosting versus DRGs in the provision of cost estimates for use in pharmacoeconomic evaluation. Expert Rev. PharmacoEconomics Outcomes Res 2002;2:29–33.CrossRef
23.
go back to reference Raikou M, Briggs A, Gray A, McGuire A. Centre-specific or average unit costs in multi-centre studies? Some theory and simulation. Health Econ 2000;9: 191–8.PubMedCrossRef Raikou M, Briggs A, Gray A, McGuire A. Centre-specific or average unit costs in multi-centre studies? Some theory and simulation. Health Econ 2000;9: 191–8.PubMedCrossRef
24.
go back to reference Tan SS, Gils CW van, Franken MG et al. The unit costs of inpatient hospital days, outpatient visits, and daycare treatments in the fields of oncology and hematology. Value Health 2010; 13:712–9.PubMedCrossRef Tan SS, Gils CW van, Franken MG et al. The unit costs of inpatient hospital days, outpatient visits, and daycare treatments in the fields of oncology and hematology. Value Health 2010; 13:712–9.PubMedCrossRef
25.
go back to reference Claxton K, Paulden M, Gravelle H, Brouwer W, Culyer AJ. Discounting and decision making in the economic evaluation of health-care technologies. Health Econ 2011;20:2–15.PubMedCrossRef Claxton K, Paulden M, Gravelle H, Brouwer W, Culyer AJ. Discounting and decision making in the economic evaluation of health-care technologies. Health Econ 2011;20:2–15.PubMedCrossRef
26.
go back to reference Brouwer WB, Niessen LW, Postma MJ, Rutten FF. Need fordifferential discounting of costs and health effects in costeffectiveness analyses. BMJ 2005;331:446–8. PubMedCrossRef Brouwer WB, Niessen LW, Postma MJ, Rutten FF. Need fordifferential discounting of costs and health effects in costeffectiveness analyses. BMJ 2005;331:446–8. PubMedCrossRef
27.
go back to reference Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Econ 2007;16:307–17.PubMedCrossRef Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Econ 2007;16:307–17.PubMedCrossRef
28.
go back to reference Briggs AH, Goeree R, Blackhouse G. Probabilistic analysis of costeffectiveness models; choosing between treatment strategies for gastroesophagal reflux disease. Medical Decision Making 2002;22:290–308.PubMed Briggs AH, Goeree R, Blackhouse G. Probabilistic analysis of costeffectiveness models; choosing between treatment strategies for gastroesophagal reflux disease. Medical Decision Making 2002;22:290–308.PubMed
Metagegevens
Titel
Handleiding voor kostenonderzoek: methoden en referentieprijzen voor economische evaluaties in de gezondheidszorg
Auteurs
Siok Swan Tan
Clazien A. M. Bouwmans-Frijters
Leona Hakkaart-van Roijen
Publicatiedatum
01-09-2012
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
TSG - Tijdschrift voor gezondheidswetenschappen / Uitgave 6/2012
Print ISSN: 1388-7491
Elektronisch ISSN: 1876-8776
DOI
https://doi.org/10.1007/s12508-012-0128-3

Andere artikelen Uitgave 6/2012

TSG - Tijdschrift voor gezondheidswetenschappen 6/2012 Naar de uitgave